IL-18 Biology in Severe Asthma
Author Information
Author(s): Thawanaphong Sarita, Nair Aswathi, Volfson Emily, Nair Parameswaran, Mukherjee Manali
Primary Institution: McMaster University
Hypothesis
This review aims to provide an overview of the current understanding of IL-18 biology and its role in severe asthma.
Conclusion
IL-18 is a key component in the pathophysiology of severe asthma, influencing both T2 and non-T2 inflammation.
Supporting Evidence
- IL-18 contributes to chronic airway inflammation and hyperresponsiveness in severe asthma.
- Emerging evidence highlights IL-18 as a critical player in both T2 and non-T2 inflammation.
- IL-18's involvement in autoimmunity suggests it may be a target for new asthma therapies.
Takeaway
IL-18 is a special protein that helps control asthma, especially in severe cases, and scientists are looking at it as a new target for treatments.
Methodology
This is a review article synthesizing recent advancements and ongoing research on IL-18 and its role in asthma.
Limitations
The review does not provide original experimental data but synthesizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website